HOME › DRUGS › PIOGLITAZONE
ACTIVE SUBSTANCE / INN

PIOGLITAZONE

Brand name(s): Glidipion (previously Pioglitazone Actavis Group), Sepioglin, Glustin, Pioglitazone ratiopharm GmbH, Pioglitazone ratiopharm, Paglitaz, Actos, Pioglitazone Krka, Pioglitazone Teva, Pioglitazone Teva Pharma, Pioglitazone Actavis, Pioglitazone ratio, Pioglitazone Teva Generics, Pioglitazone Accord
EMA LISTED
LAPSED
APPLICATION WITHDRAWN
WITHDRAWN
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Pioglitazone
REGULATORS
EMA
SPONSORS / MAH
Takeda Pharma A/S, CHEPLAPHARM Arzneimittel GmbH, Vaia S.A.
TOTAL APPLICATIONS
14
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Pioglitazone AccordAccord Healthcare S.L.U.Authorised21/03/2012Diabetes Mellitus, Type 2
ActosCHEPLAPHARM Arzneimittel GmbHAuthorised13/10/2000Diabetes Mellitus, Type 2
Pioglitazone ActavisActavis Group PTC ehfAuthorised15/03/2012Diabetes Mellitus, Type 2
Pioglitazone TevaTeva B.V.Withdrawn26/03/2012Diabetes Mellitus, Type 2
Glidipion (previously Pioglitazone Actavis Group)Actavis Group PTC ehfWithdrawn15/03/2012Diabetes Mellitus, Type 2
GlustinTakeda Pharma A/SWithdrawn11/10/2000Diabetes Mellitus, Type 2
Pioglitazone Teva PharmaTeva Pharma B.V.Withdrawn26/03/2012Diabetes Mellitus, Type 2
PaglitazKrka, d.d., Novo mestoLapsed21/03/2012Diabetes Mellitus, Type 2
Pioglitazone KrkaKrka, d.d., Novo mestoWithdrawn21/03/2012Diabetes Mellitus, Type 2
SepioglinVaia S.A.Withdrawn09/03/2012Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON PIOGLITAZONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →